Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
References Tesamorelin LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institutes of Health, NIDDK (2018) Tesamorelin (Subcutaneous route) Drug Information Mayo Clinic / IBM Merative (2025) Effects of tesamorelin (TH9507), a growth hormonereleasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials J
By combining the genomic remodeling power of GHK-Cu with the angiogenic precision of BPC-157 and the cytoskeletal mobility of TB-500, this blend addresses the three pillars of tissue regeneration: Structure, Supply, and Mobility
Request lot-specific analytical documentation Review whether the certificate of analysis identifies the batch, testing date, methods, specifications, and results
All products are tested and verified to meet regulatory and safety guidelines
Revised: January 2026 ZEPKP-0002-IFU-20260121 PACKAGE LABEL - Zepbound Prefilled Pen (Autoinjector) - 2.5 mg/0.5 mL Dose NDC 0002-2506-80 Zepbound (tirzepatide) injection 2.5 mg/0.5 mL 4 x 2.5 mg/0.5 mL prefilled pens Rx Only For Subcutaneous Use Dispense enclosed Medication Guide to each patient
US$ 21.43
US$ 22.73
US$ 24.56
US$ 28.40
US$ 28.67
